Posted by The 4th Annual Injectable Drug Delivery Conference will be held on 11th and 12th May 2022 in London, UK.
There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% reaching £915 billion by 2027.
This year’s event will highlight the significance of sustainability within the injectable drug delivery industry, whilst also providing regulatory insight on the changes that have occurred. There will be an additional focus on the impact that covid has had on the success within this industry over the past year. The conference will also highlight successes within the industry and the formulation challenges of long-lasting, highly viscous and high volume drug delivery. Find out more and visit the website here >>
Invited Chairs For 2022:
- Joel Richard, Chief Development Officer, MedinCell
- Rene Holm, Professor, University of Southern Denmark
Featured 2022 Speakers Include:
- Cristiana Heese, Packaging Engineer, Boehringer Ingelheim
- Michael Becker, Packaging Engineer, Boehringer Ingelheim
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer
- David Deutsch, Leading Senior Pharmaceutical Assessor,Licensing Division, Mhra
- Steve Chamberlain, Director Device Engineering, GSK
- Conor o’neill, Head of Packaging Development, GSK
- Harriet Lewis, Head of Public Affairs, Market Access and Public Affairs, Chiesi
- Fiona Adshead, Chair, sustainable healthcare Coalition
- Clemens günther, Director Senior Expert Nonclinical Safety, Bayer
- Prashant Bhatia, Associate Director, Medical Devices & Combination Products, AstraZeneca